← Back to patent-cliff list
CAS 1320343-65-4
(S,E)-5-(carbamoylimino)-4-hydroxy-2-oxoimidazolidine-4-carboxylate
Codes: ALLA-003
Application context (from source-drug indications)
大疱性表皮松解症Allantoin皮肤性疾病Allantoin瘢痕AllantoinMarginal zone B-cell lymphomaAllantoinLymphomaAllantoinFollicular lymphomaAllantoin
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Allantoin | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
6,8-dioxo-6,7,8,9-tetrahydro-1H-purin-2-olate→(S)-5-hydroxy-2,6-dioxo-2,5,6,7-tetrahydro-1H-purin-8-olate→(S,E)-5-(carbamoylimino)-4-hydroxy-2-oxoimidazolidine-4-carboxylate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.